评估患者和家属对急性和预防性儿科头痛治疗的偏好。

IF 5.4 2区 医学 Q1 CLINICAL NEUROLOGY Headache Pub Date : 2024-09-01 Epub Date: 2024-06-03 DOI:10.1111/head.14739
Elise G Martin, Jonathan Kuziek, Jananee Rasiah, Serena L Orr
{"title":"评估患者和家属对急性和预防性儿科头痛治疗的偏好。","authors":"Elise G Martin, Jonathan Kuziek, Jananee Rasiah, Serena L Orr","doi":"10.1111/head.14739","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe acute and preventive treatment preferences among youth with migraine and their parents/guardians, and to describe the degree of youth-parent/guardian preference agreement.</p><p><strong>Background: </strong>Headache disorders are common in youth, but little is known about patient and family preferences for headache treatments and outcomes.</p><p><strong>Methods: </strong>In this cross-sectional survey, a headache treatment preferences questionnaire was co-created with stakeholders, piloted, and distributed to consenting youth with migraine aged 9-18 years and parents/guardians at a tertiary care headache clinic in western Canada. Response data were summarized for youth and parents/guardians separately, and agreement rates within a youth-parent/guardian pair were compared to a hypothesized agreement rate of 80% for the primary questionnaire items.</p><p><strong>Results: </strong>Seventy-two youth and n = 94 parents/guardians participated, with n = 63 in youth-parent/guardian pairs. Freedom from pain and rapid relief, and reducing pain severity and headache frequency were top acute and preventive treatment priorities, respectively. More than 90% (69/72) agreed that ≥ 50% reduction in headache frequency was a good target. For both acute and preventive interventions, swallowed pill-based options were most often selected as the preferred first-line treatment, with neuromodulation selected as the preferred second-line treatment. The level of agreement within youth-parent/guardian pairs on preferred treatment modalities was lower than hypothesized for acute (63% [40/63], 95% confidence interval [CI] = 52-75%, χ<sup>2</sup> = 10.73, p = 0.001) but not for preventive treatment (73% [46/63], 95% CI = 62-84%, χ<sup>2</sup> = 1.92, p = 0.166). Regarding which treatment modalities were perceived as most effective, youth-parent agreement was lower than hypothesized for both acute (48% [30/63], 95% CI = 35-60%, χ<sup>2</sup> = 41.29, p < 0.001) and preventive treatment (46% [29/63], 95% CI = 34-58%, χ<sup>2</sup> = 45.43, p < 0.001).</p><p><strong>Conclusion: </strong>Youth and family preferences aligned qualitatively, but sometimes diverged quantitatively, from typical clinical trial outcomes. The level of agreement within youth-parent/guardian pairs on treatment preferences and perceptions was low. Clinicians should consider both perspectives as they may be divergent.</p>","PeriodicalId":12844,"journal":{"name":"Headache","volume":" ","pages":"950-966"},"PeriodicalIF":5.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluating patient and family preferences for acute and preventive pediatric headache treatment.\",\"authors\":\"Elise G Martin, Jonathan Kuziek, Jananee Rasiah, Serena L Orr\",\"doi\":\"10.1111/head.14739\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To describe acute and preventive treatment preferences among youth with migraine and their parents/guardians, and to describe the degree of youth-parent/guardian preference agreement.</p><p><strong>Background: </strong>Headache disorders are common in youth, but little is known about patient and family preferences for headache treatments and outcomes.</p><p><strong>Methods: </strong>In this cross-sectional survey, a headache treatment preferences questionnaire was co-created with stakeholders, piloted, and distributed to consenting youth with migraine aged 9-18 years and parents/guardians at a tertiary care headache clinic in western Canada. Response data were summarized for youth and parents/guardians separately, and agreement rates within a youth-parent/guardian pair were compared to a hypothesized agreement rate of 80% for the primary questionnaire items.</p><p><strong>Results: </strong>Seventy-two youth and n = 94 parents/guardians participated, with n = 63 in youth-parent/guardian pairs. Freedom from pain and rapid relief, and reducing pain severity and headache frequency were top acute and preventive treatment priorities, respectively. More than 90% (69/72) agreed that ≥ 50% reduction in headache frequency was a good target. For both acute and preventive interventions, swallowed pill-based options were most often selected as the preferred first-line treatment, with neuromodulation selected as the preferred second-line treatment. The level of agreement within youth-parent/guardian pairs on preferred treatment modalities was lower than hypothesized for acute (63% [40/63], 95% confidence interval [CI] = 52-75%, χ<sup>2</sup> = 10.73, p = 0.001) but not for preventive treatment (73% [46/63], 95% CI = 62-84%, χ<sup>2</sup> = 1.92, p = 0.166). Regarding which treatment modalities were perceived as most effective, youth-parent agreement was lower than hypothesized for both acute (48% [30/63], 95% CI = 35-60%, χ<sup>2</sup> = 41.29, p < 0.001) and preventive treatment (46% [29/63], 95% CI = 34-58%, χ<sup>2</sup> = 45.43, p < 0.001).</p><p><strong>Conclusion: </strong>Youth and family preferences aligned qualitatively, but sometimes diverged quantitatively, from typical clinical trial outcomes. The level of agreement within youth-parent/guardian pairs on treatment preferences and perceptions was low. Clinicians should consider both perspectives as they may be divergent.</p>\",\"PeriodicalId\":12844,\"journal\":{\"name\":\"Headache\",\"volume\":\" \",\"pages\":\"950-966\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Headache\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/head.14739\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Headache","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/head.14739","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的描述患有偏头痛的青少年及其父母/监护人对急性和预防性治疗的偏好,并描述青少年与父母/监护人偏好的一致程度:背景:头痛疾病在青少年中很常见,但患者及家属对头痛治疗方法和结果的偏好却知之甚少:在这项横断面调查中,我们与利益相关者共同制作了一份头痛治疗偏好问卷,并在加拿大西部一家三级头痛诊所进行了试用,并在征得患有偏头痛的 9-18 岁青少年和家长/监护人同意后进行了分发。对青少年和家长/监护人的回复数据分别进行了汇总,并将青少年与家长/监护人之间的意见一致率与主要问卷项目80%的假设一致率进行了比较:72名青少年和n=94名家长/监护人参加了调查,其中n=63名青少年和家长/监护人结成对子。免于疼痛和快速缓解疼痛以及降低疼痛严重程度和头痛频率分别是急性和预防性治疗的首要任务。超过 90%(69/72)的人认为头痛频率降低≥50% 是一个很好的目标。对于急性和预防性干预,吞服药片疗法最常被选为首选的一线治疗方法,而神经调节疗法则被选为首选的二线治疗方法。在急性期治疗中,青少年-家长/监护人对首选治疗方式的一致程度低于假设(63% [40/63],95% 置信区间 [CI] = 52-75%,χ2 = 10.73,p = 0.001),但在预防性治疗中,这一一致程度并不低于假设(73% [46/63],95% 置信区间 [CI] = 62-84%,χ2 = 1.92,p = 0.166)。在认为哪种治疗方式最有效的问题上,青少年和家长对两种急性期治疗方式的认同度均低于预期(48% [30/63],95% CI = 35-60%,χ2 = 41.29,P 2 = 45.43,P 结论:青少年和家庭对急性期治疗方式的选择在质量上是一致的:青少年和家庭的偏好在质量上与典型的临床试验结果一致,但有时在数量上存在差异。青少年与父母/监护人之间在治疗偏好和看法上的一致程度较低。临床医生应考虑这两种观点,因为它们可能存在分歧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluating patient and family preferences for acute and preventive pediatric headache treatment.

Objective: To describe acute and preventive treatment preferences among youth with migraine and their parents/guardians, and to describe the degree of youth-parent/guardian preference agreement.

Background: Headache disorders are common in youth, but little is known about patient and family preferences for headache treatments and outcomes.

Methods: In this cross-sectional survey, a headache treatment preferences questionnaire was co-created with stakeholders, piloted, and distributed to consenting youth with migraine aged 9-18 years and parents/guardians at a tertiary care headache clinic in western Canada. Response data were summarized for youth and parents/guardians separately, and agreement rates within a youth-parent/guardian pair were compared to a hypothesized agreement rate of 80% for the primary questionnaire items.

Results: Seventy-two youth and n = 94 parents/guardians participated, with n = 63 in youth-parent/guardian pairs. Freedom from pain and rapid relief, and reducing pain severity and headache frequency were top acute and preventive treatment priorities, respectively. More than 90% (69/72) agreed that ≥ 50% reduction in headache frequency was a good target. For both acute and preventive interventions, swallowed pill-based options were most often selected as the preferred first-line treatment, with neuromodulation selected as the preferred second-line treatment. The level of agreement within youth-parent/guardian pairs on preferred treatment modalities was lower than hypothesized for acute (63% [40/63], 95% confidence interval [CI] = 52-75%, χ2 = 10.73, p = 0.001) but not for preventive treatment (73% [46/63], 95% CI = 62-84%, χ2 = 1.92, p = 0.166). Regarding which treatment modalities were perceived as most effective, youth-parent agreement was lower than hypothesized for both acute (48% [30/63], 95% CI = 35-60%, χ2 = 41.29, p < 0.001) and preventive treatment (46% [29/63], 95% CI = 34-58%, χ2 = 45.43, p < 0.001).

Conclusion: Youth and family preferences aligned qualitatively, but sometimes diverged quantitatively, from typical clinical trial outcomes. The level of agreement within youth-parent/guardian pairs on treatment preferences and perceptions was low. Clinicians should consider both perspectives as they may be divergent.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Headache
Headache 医学-临床神经学
CiteScore
9.40
自引率
10.00%
发文量
172
审稿时长
3-8 weeks
期刊介绍: Headache publishes original articles on all aspects of head and face pain including communications on clinical and basic research, diagnosis and management, epidemiology, genetics, and pathophysiology of primary and secondary headaches, cranial neuralgias, and pains referred to the head and face. Monthly issues feature case reports, short communications, review articles, letters to the editor, and news items regarding AHS plus medicolegal and socioeconomic aspects of head pain. This is the official journal of the American Headache Society.
期刊最新文献
Safety and tolerability of ubrogepant for the acute treatment of migraine in participants taking atogepant for the preventive treatment of episodic migraine: Results from the TANDEM study. Anxiety, depression, and headache-related disability in a large pediatric clinic-based sample. Associations of comorbid headache disorders and depression with leisure-time physical activity among 14,088 adults in The Brazilian Longitudinal Study of Adult Health. Magnetoencephalography studies in migraine and headache disorders: A systematic review. Comparative bioavailability of single-dose zavegepant during and between migraine attacks: A phase 1, randomized, open-label, fixed-sequence, two-period study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1